Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma von Kurtz, David M, Scherer, Florian, Jin, Michael C, Soo, Joanne, Craig, Alexander F M, Esfahani, Mohammad Shahrokh, Chabon, Jacob J, Stehr, Henning, Liu, Chih Long, Tibshirani, Robert, Maeda, Lauren S, Gupta, Neel K, Khodadoust, Michael S, Advani, Ranjana H, Levy, Ronald, Newman, Aaron M, Dührsen, Ulrich, Hüttmann, Andreas, Meignan, Michel, Casasnovas, René-Olivier, Westin, Jason R, Roschewski, Mark, Wilson, Wyndham H, Gaidano, Gianluca, Rossi, Davide, Diehn, Maximilian, Alizadeh, Ash A

Volltext

Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction von Kurtz, David M., Esfahani, Mohammad S., Scherer, Florian, Soo, Joanne, Jin, Michael C., Liu, Chih Long, Newman, Aaron M., Dührsen, Ulrich, Hüttmann, Andreas, Casasnovas, Olivier, Westin, Jason R., Ritgen, Matthais, Böttcher, Sebastian, Langerak, Anton W., Roschewski, Mark, Wilson, Wyndham H., Gaidano, Gianluca, Rossi, Davide, Bahlo, Jasmin, Hallek, Michael, Tibshirani, Robert, Diehn, Maximilian, Alizadeh, Ash A.

Volltext

Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA von Kurtz, David M., Soo, Joanne, Co Ting Keh, Lyron, Alig, Stefan, Chabon, Jacob J., Sworder, Brian J., Schultz, Andre, Jin, Michael C., Scherer, Florian, Garofalo, Andrea, Macaulay, Charles W., Hamilton, Emily G., Chen, Binbin, Olsen, Mari, Schroers-Martin, Joseph G., Craig, Alexander F. M., Moding, Everett J., Esfahani, Mohammad S., Liu, Chih Long, Dührsen, Ulrich, Hüttmann, Andreas, Casasnovas, René-Olivier, Westin, Jason R., Roschewski, Mark, Wilson, Wyndham H., Gaidano, Gianluca, Rossi, Davide, Diehn, Maximilian, Alizadeh, Ash A.

Volltext

Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma von Alig, Stefan, Macaulay, Charles W, Kurtz, David M, Dührsen, Ulrich, Hüttmann, Andreas, Schmitz, Christine, Jin, Michael C, Sworder, Brian J, Garofalo, Andrea, Shahrokh Esfahani, Mohammad, Nabet, Barzin Y, Soo, Joanne, Scherer, Florian, Craig, Alexander F M, Casasnovas, Olivier, Westin, Jason R, Gaidano, Gianluca, Rossi, Davide, Roschewski, Mark, Wilson, Wyndham H, Meignan, Michel, Diehn, Maximilian, Alizadeh, Ash A

Volltext

Specificity & Precision of Minimal Residual Disease Monitoring in DLBCL Using Ig-HTS von Shukla, Navika D., Schroers-Martin, Joseph, Kathuria, Karan R., Sworder, Brian, Alig, Stefan K., Frank, Matthew J, Miklos, David B., Coutre, Steven, Diehn, Maximilian, Khodadoust, Michael S., Roschewski, Mark, Kurtz, David M., Alizadeh, Ash A.

Volltext

Multi-Component, Time-Course screening to develop combination cancer therapies based on synergistic toxicity von Ceribelli, Michele, Tosto, Frances Anne, Zhang, Xiaohu, Melani, Christopher J, Roschewski, Mark, Beck, Erin, Klumpp-Thomas, Carleen, Peer, Cody J, Wilson, Kelli M, Chen, Lu, McKnight, Crystal, Michael, Sam, Itkin, Zina, Shinn, Paul, Figg, Sr, William D, Wilson, Wyndham H, Staudt, Louis M, Thomas, Craig J

Volltext

Fixed Duration Combination Therapy with Carfilzomib, Lenalidomide, and Dexamethasone Followed By Lenalidomide Maintenance Leads to High Rates of Sustained MRD Negativity in Patient... von Hill, Elizabeth, Roswarski, Joseph L., Bhaskarla, Amrit, Dew, Alexander, Morrison, Candis, Emanuel, Michael, Petrosyan, Ani, Wang, Hao-Wei, Yuan, Constance M., Lindenberg, Liza, Mena, Esther, Turkbey, Baris, Patel, Nisha, Maric, Irina, Dulau-Florea, Alina, Calvo, Katherine, Braylan, Raul C., Stetler-Stevenson, Maryalice, Steinberg, Seth M., Figg, William, Young, Ryan M., Landgren, Ola, Roschewski, Mark, Kazandjian, Dickran

Volltext

Phase 2 Response-Adapted Study of Ibrutinib with Temozolomide, Etoposide, Liposomal Doxorubicin, Dexamethasone, and Rituximab (TEDDI-R) for Secondary CNS Lymphoma von Simard, Jillian, Phelan, James D, Melani, Christopher, Lakhotia, Rahul, Pittaluga, Stefania, Muppidi, Jagan R., Lionakis, Michail, Peer, Cody J, Pradhan, Amynah, Holdhoff, Matthias, Swinnen, Lode J., Dunleavy, Kieron, Lai, Catherine, Ibrahimi, Sami, Glantz, Michael, Butman, John A, Johnson, Kim, Steinberg, Seth M., Figg, William, Jaffe, Elaine S., Staudt, Louis M., Wilson, Wyndham H., Roschewski, Mark

Volltext

Specificity of immunoglobulin high-throughput sequencing minimal residual disease monitoring in non-Hodgkin lymphomas von Shukla, Navika D., Schroers-Martin, Joseph G., Sworder, Brian J., Kathuria, Karan Raj, Alig, Stefan K., Frank, Matthew J., Miklos, David B., Coutre, Steven, Diehn, Maximilian, Khodadoust, Michael S., Roschewski, Mark, Kurtz, David M., Alizadeh, Ash A.

Volltext

Bewertung von Objektmanagementsystemen für Software-Entwicklungsumgebungen von Dewal, Sanjay, Hormann, Harry, Schöpe, Lothar, Kelter, Udo, Platz, Dirk, Roschewski, Michael

Volltext

Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients von Radtke, Andrea J., Postovalova, Ekaterina, Varlamova, Arina, Bagaev, Alexander, Sorokina, Maria, Kudryashova, Olga, Meerson, Mark, Polyakova, Margarita, Galkin, Ilia, Svekolkin, Viktor, Isaev, Sergey, Wiebe, Daniil, Sharun, Anna, Sarachakov, Alexander, Perelman, Grigory, Lozinsky, Yaroslav, Yaniv, Ziv, Lowekamp, Bradley C., Speranza, Emily, Yao, Li, Pittaluga, Stefania, Shaffer, Arthur L., Jonigk, Danny, Phelan, James D., Davies-Hill, Theresa, Huang, Da Wei, Ovcharov, Pavel, Nomie, Krystle, Nuzhdina, Ekaterina, Kotlov, Nikita, Ataullakhanov, Ravshan, Fowler, Nathan, Kelly, Michael, Muppidi, Jagan, Davis, Jeremy L., Hernandez, Jonathan M., Wilson, Wyndham H., Jaffe, Elaine S., Staudt, Louis M., Roschewski, Mark, Germain, Ronald N.

Volltext

Reponse-Adapted Study of Ibrutinib with Temozolomide, Etoposide, Doxil, Dexamethasone, and Rituximab (TEDDI-R) in Aggressive B-Cell Lymphomas with Secondary Involvement of the CNS von Roschewski, Mark, Melani, Christopher, Dunleavy, Kieron, Holdhoff, Matthias, Swinnen, Lode J., Glantz, Michael, Portell, Craig A., Svoboda, Jakub, Farah, Rafic, Lionakis, Michail S., Staudt, Louis, Wilson, Wyndham

Volltext

Tisagenlecleucel Demonstrates Safety, Efficacy and CNS Trafficking in Primary CNS Lymphoma von Frigault, Matthew J., Dietrich, Jorg, Gallagher, Kathleen M.E., Scarfò, Irene, Roschewski, Mark, Jordan, Justin T, Forst, Deborah A., Plotkin, Scott R, Cook, Daniella, Casey, Keagan, Katsis, Katelin, Lindell, Kevin, Trailor, Michael, Horick, Nora, McAfee, Steven, O'Donnell, Paul V, Spitzer, Thomas R, Dey, Bimalangshu R, Defilipp, Zachariah, El-Jawahri, Areej, Batchelor, Tracy, Maus, Marcela V., Chen, Yi-Bin

Volltext

Phased variants improve DLBCL minimal residual disease detection at the end of therapy von Kurtz, David Matthew, Chabon, Jacob J., Soo, Joanne, Co Ting Keh, Lyron, Alig, Stefan, Schultz, Andre, Jin, Michael C., Scherer, Florian, Craig, Alexander F.M., Liu, Chih Long, Duehrsen, Ulrich, Huettmann, Andreas, Casasnovas, René-Olivier, Westin, Jason, Roschewski, Mark J., Wilson, Wyndham Hopkins, Gaidano, Gianluca, Rossi, Davide, Diehn, Maximilian, Alizadeh, Ash A.

Volltext

Preliminary Results of a Response-Adapted Study of Ibrutinib and Isavuconazole with Temozolomide, Etoposide, Liposomal Doxorubicin, Dexamethasone, Rituximab (TEDDI-R) for Secondary... von Simard, Jillian, Melani, Christopher, Lakhotia, Rahul, Lionakis, Michail S., Pittaluga, Stefania, Phelan, James D., Muppidi, Jagan R., Chou, Lydia L., Holdhoff, Matthias, Glantz, Michael, Butman, John A., Lucas, Andrea Nicole, Steinberg, Seth M., Jaffe, Elaine S., Staudt, Louis M., Wilson, Wyndham H., Roschewski, Mark

Volltext

Phase 1 Study of Escalating Doses of Ibrutinib and Temozolomide, Etoposide, Liposomal Doxorubicin, Dexamethasone, Rituximab (TEDDI-R) with Isavuconazole for Relapsed and Refractory... von Roschewski, Mark, Melani, Christopher, Lakhotia, Rahul, Pittaluga, Stefania, Phelan, James D., Peer, Cody, Lionakis, Michail S., Chou, Lydia L., Holdhoff, Matthias, Glantz, Michael, Drappatz, Jan, Lai, Catherine, Butman, John A., Lucas, Andrea Nicole, Steinberg, Seth M., Figg, William D., Jaffe, Elaine S., Ivy, S. Percy, Little, Richard F., Staudt, Louis M., Wilson, Wyndham H.

Volltext

ABCL-187 Phase 2 Response-Adapted Study of Ibrutinib With Temozolomide, Etoposide, Liposomal Doxorubicin, Dexamethasone, Rituximab (TEDDI-R) for Secondary CNS Lymphoma von Simard, Jillian, Phelan, James D, Melani, Christopher, Lakhotia, Rahul, Pittaluga, Stefania, Muppidi, Jagan R, Lionakis, Michail S, Peer, Cody, Pradhan, Amynah, Holdhoff, Matthias, Swinnen, Lode J, Dunleavy, Kieron, Lai, Catherine, Ibrahimi, Sami, Glantz, Michael, Butman, John A, Johnson, Kim, Steinberg, Seth M, Figg, William D, Jaffe, Elaine S, Staudt, Louis M, Wilson, Wyndham H, Roschewski, Mark

Volltext

POSTER: ABCL-187 Phase 2 Response-Adapted Study of Ibrutinib With Temozolomide, Etoposide, Liposomal Doxorubicin, Dexamethasone, Rituximab (TEDDI-R) for Secondary CNS Lymphoma von Simard, Jillian, Phelan, James D, Melani, Christopher, Lakhotia, Rahul, Pittaluga, Stefania, Muppidi, Jagan R, Lionakis, Michail S, Peer, Cody, Pradhan, Amynah, Holdhoff, Matthias, Swinnen, Lode J, Dunleavy, Kieron, Lai, Catherine, Ibrahimi, Sami, Glantz, Michael, Butman, John A, Johnson, Kim, Steinberg, Seth M, Figg, William D, Jaffe, Elaine S, Staudt, Louis M, Wilson, Wyndham H, Roschewski, Mark

Volltext

Treatment of High Risk (HR) Smoldering Multiple Myeloma (SMM) with Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed By Lenalidomide Maintenance (-R): A Phase 2 Clinical... von Kazandjian, Dickran, Hill, Elizabeth, Morrison, Candis, Dew, Alexander, Korde, Neha, Mailankody, Sham, Manasanch, Elisabet E., Kwok, Mary L., Bhutani, Manisha, Tageja, Nishant, Zhang, Yong, Carpenter, Ashley, Epstein, Monica, Emanuel, Michael, Lu, Crystal, Braylan, Raul C., Calvo, Katherine R., Choyke, Peter, Dulau-Florea, Alina, Mena, Esther, Lindenberg, Liza, Maric, Irina, Patel, Nisha, Stetler-Stevenson, Maryalice, Wang, Hao-Wei, Yuan, Constance M., Steinberg, Seth M., Figg, William D., Roschewski, Mark, Landgren, Ola

Volltext

Integration and Iteration: Using Advanced, High-Content Imaging and Single-Cell Gene Expression Analysis to Uncover Unique Aspects of Follicular Lymphoma Biology von Radtke, Andrea J., Shaffer, Arthur L., Pittaluga, Stefania, Bagaev, Alexander, Thakur, Nishant, Davies-Hill, Theresa, Plotnikova, Olga, Galkin, Ilia, Postovalova, Ekaterina, Svekolkin, Viktor, Isaev, Sergei, Lozinsky, Yaroslav, Meerson, Mark, Varlamova, Arina, Ovcharov, Pavel, Polyakova, Margarita, Nomie, Krystle, Nuzhdina, Ekaterina, Kotlov, Nikita, Tsiper, Maria, Frenkel, Felix, Attaulakhanov, Ravshan, Fowler, Nathan H, Yaniv, Ziv, Lowekamp, Bradley C, Kelly, Michael, Dadkhah, Ezzat, Huang, Da Wei, Muppidi, Jagan R., Jaffe, Elaine S., Wilson, Wyndham H., Staudt, Louis M., Germain, Ronald N., Roschewski, Mark

Volltext